Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Thermo Fisher Scientific and Charles River Laboratories layoff employees across locations Massachusetts.
November 11, 2024
By: Kristin Brooks
Managing Editor, Contract Pharma
Layoffs in the biopharma sector contunue into 4Q 2024. November Thermo Fisher Scientific will lay off 160 employees across locations in Lexington, Plainville and Cambridge, MA between January 6, 2025 and November 6, 2026, according to a Worker Adjustment and Retraining Notification Act notice dated November 7. Thermo Fisher plans to close the 50,000-sq.-ft. CDMO site in Lexington, which opened in 2019 and provides development, testing and manufacture of viral vectors. The 290,000-sq.-ft. facility in Plainville provides viral vector services ranging from process development to commercial manufacturing. Charles River Laboratories restructuring initiatives include laying off more than 1,300 employees since 2023, or approximately 6% of its workforce, according to Boston Business Journal. Additionally, in its 3Q24 earnings, Charles River stated that it is closing or consolidating 15 smaller sites that focus on discovery and safety assessment and regulatory management services. October Pfizer is laying off 75 additional employees in Sanford, NC. Pfizer previously cut 150 positions in Sanford following a Phase 3 trial failure for its Duchenne muscular dystrophy gene therapy candidate. Evonik is restructuring to focus on its strategic core growth areas. Evonik will evaluate strategic options, such as partnerships or divestment, for developing its keto and pharma amino acid production sites in Ham and Wuming. It is also planning to discontinue its production of keto acids in Hanau by the end of 2025, affecting around 260 employees. Evonik’s keto and pharma amino acid business generates an annual average revenue of around 100 million euros. Johnson & Johnson is laying off 231 employees at its New Brunswick, NJ, headquarters effective December 27, 2024 according to a Worker Adjustment and Retraining Notification Act notice. The company did not make an announcement regarding the layoffs. Bayer is laying off 57 employees at its Whippany, NJ, headquarters effective December 27, 2024 according to a Worker Adjustment and Retraining Notification Act notice. The company did not make an announcement regarding the layoffs. Other recent cuts at Bayer include cutting 14 to 18 executive team members and eliminating 1,500 jobs, in May. September Bristol Myers Squibb’s most recent layoffs in Lawrenceville, NJ, involve 79 employees, effective between December 12 and May 30, bringing the total number of positions cut at the site to 1,134, according to Worker Adjustment and Retraining Notification Act notices. AGC Biologics, a CDMO, will lay off 95 employees, effective November 22, 2024 according to Worker Adjustment and Retraining Notification Act notices. The company did not make an announcement regarding the layoffs. Charles River Labs is laying off 3% of its workforce, or approximately 650 people. According to an Aug. 2 Worker Adjustment and Retraining Notification Act notice, 13 workers in Frederick, MD, are being let go effective September 30. April Bristol Myers Squibb in its 1Q results announced a Strategic Productivity Initiative aimed at $1.5 billion in cost savings by the end of 2025. This includes laying off more than 2,200 employees. The restructuring plans are across the business, including site closures and R&D spending, a reduction of management layers and reduce third-party spending. Genentech plans to cut approximately 405 positions or 3% of its workforce across “several departments,” a spokesperson confirmed, as reported by Endpoints News. Earlier this year, parent company Roche announced cuts to its product development team.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !